Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
BEAM-101
Beam Therapeutics
Sickle Cell Disease
1 trial -
BEAM-201
Beam Therapeutics
Lymphoblastic Lymphoma
1 trial -
BEAM-301: Single dose of BEAM-301 administered by IV
Beam Therapeutics
Glycogen Storage Disease Type Ia
1 trial -
BEAM-302
Beam Therapeutics
Alpha 1-Antitrypsin Deficiency
1 trial -
BEAM-302
Beam Therapeutics
Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or Liver Disease
1 trial -
Allogeneic anti-CD7 CAR-T cells (BEAM-201)
Beam Therapeutics
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
1 trial -
BEAM-103
Beam Therapeutics
Healthy Subjects
1 trial -
Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes in the HER2 gene)
Boehringer Ingelheim
Solid tumours with HER2 aberrations, Non-small cell lung cancer
1 trial -
BEAM Dream Powder
Beam Therapeutics
Sleep
1 trial -
Beam Organics Dream Powder
Beam Therapeutics
Sleep
1 trial -
Cone Beam Computed Tomography scanning (CBCT)
United Therapeutics Europe Ltd
Endodontic Disease
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
PRDR
Beam Therapeutics
Glioma
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources